All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Neoplasms-30008422

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30008422	A143T	E2	E2	Uterine Cervical Neoplasms	G R L	View
2	30008422	A3181C	E2	E2	Uterine Cervical Neoplasms	G R L	View
3	30008422	A3362G	E2	E2	Uterine Cervical Neoplasms	G R L	View
4	30008422	A3538C	E2	E2	Uterine Cervical Neoplasms	G R L	View
5	30008422	C251F	E2	E2	Uterine Cervical Neoplasms	G R L	View
6	30008422	C2860A	E2	E2	Uterine Cervical Neoplasms	G R L	View
7	30008422	C3377G	E2	E2	Uterine Cervical Neoplasms	G R L	View
8	30008422	C3516A	E2	E2	Uterine Cervical Neoplasms	G R L	View
9	30008422	D173E	E2	E2	Uterine Cervical Neoplasms	G R L	View
10	30008422	D173N	E2	E2	Uterine Cervical Neoplasms	G R L	View
11	30008422	E142D	E2	E2	Uterine Cervical Neoplasms	G R L	View
12	30008422	F168Y	E2	E2	Uterine Cervical Neoplasms	G R L	View
13	30008422	F271V	E2	E2	Uterine Cervical Neoplasms	G R I L	View
14	30008422	G150G	E2	E2	Uterine Cervical Neoplasms	G R L	View
15	30008422	G3182A	E2	E2	Uterine Cervical Neoplasms	G R L	View
16	30008422	G3272A	E2	E2	Uterine Cervical Neoplasms	G R L	View
17	30008422	G3307T	E2	E2	Uterine Cervical Neoplasms	G R L	View
18	30008422	G3507T	E2	E2	Uterine Cervical Neoplasms	G R L	View
19	30008422	G3778T	E2	E2	Uterine Cervical Neoplasms	G R I L	View
20	30008422	H35Q	E2	E2	Uterine Cervical Neoplasms	G R L	View
21	30008422	I211T	E2	E2	Uterine Cervical Neoplasms	G R L	View
22	30008422	L157I	E2	E2	Uterine Cervical Neoplasms	G R L	View
23	30008422	N203D	E2	E2	Uterine Cervical Neoplasms	G R L	View
24	30008422	P208A	E2	E2	Uterine Cervical Neoplasms	G R L	View
25	30008422	S261S	E2	E2	Uterine Cervical Neoplasms	G R L	View
26	30008422	S274A	E2	E2	Uterine Cervical Neoplasms	G R I L	View
27	30008422	S317S	E2	E2	Uterine Cervical Neoplasms	G R L	View
28	30008422	T254N	E2	E2	Uterine Cervical Neoplasms	G R I L	View
29	30008422	T313T	E2	E2	Uterine Cervical Neoplasms	G R L	View
30	30008422	T3205C	E2	E2	Uterine Cervical Neoplasms	G R L	View
31	30008422	T3224A	E2	E2	Uterine Cervical Neoplasms	G R L	View
32	30008422	T3258A	E2	E2	Uterine Cervical Neoplasms	G R L	View
33	30008422	T3274G	E2	E2	Uterine Cervical Neoplasms	G R L	View
34	30008422	T3387C	E2	E2	Uterine Cervical Neoplasms	G R L	View
35	30008422	T3517C	E2	E2	Uterine Cervical Neoplasms	G R I L	View
36	30008422	T3566G	E2	E2	Uterine Cervical Neoplasms	G R I L	View
37	30008422	T3575G	E2	E2	Uterine Cervical Neoplasms	G R I L	View
38	30008422	T3664C	E2	E2	Uterine Cervical Neoplasms	G R L	View
39	30008422	T3694A	E2	E2	Uterine Cervical Neoplasms	G R L	View
40	30008422	T3706C	E2	E2	Uterine Cervical Neoplasms	G R L	View
41	30008422	T3805G	E2	E2	Uterine Cervical Neoplasms	G R L	View
42	30008422	V350V	E2	E2	Uterine Cervical Neoplasms	G R L	View
43	30008422	W184C	E2	E2	Uterine Cervical Neoplasms	G R L	View
44	30008422	W341C	E2	E2	Uterine Cervical Neoplasms	G R I L	View
45	30008422	Y303Y	E2	E2	Uterine Cervical Neoplasms	G R L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.